Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Suzhou Hosptial of Traditional Chinese Medicine | UNKNOWN |
| Shandong University of Traditional Chinese Medicine | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lifestyle intervention + Songling Xuemaikang Capsules | Experimental |
|
|
| Lifestyle intervention + placebo | Placebo Comparator |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Songling Xuemaikang Capsules | Drug | 3 capsules at a time, three times a day, duration: 12 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in the Mean 24h Systolic Blood Pressure at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in the ba-PWV at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the skin capillary density(SCD) at 4,12 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Anlu Wang, Doctor | Contact | 010-62835342 | wwanganlu@126.com | |
| Qiyu Liu, Doctor | Contact | 010-18810722937 | liuqy9307@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Hao Xu, Prof. | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | Recruiting | Beijing | Beijing Municipality | 100091 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33019798 | Background | Zhang DY, Cheng YB, Guo QH, Shan XL, Wei FF, Lu F, Sheng CS, Huang QF, Yang CH, Li Y, Wang JG. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial. Circulation. 2020 Nov 10;142(19):1821-1830. doi: 10.1161/CIRCULATIONAHA.120.046685. Epub 2020 Oct 6. | |
| 40770317 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Lifestyle intervention | Behavioral | everyday, duration: 12 weeks |
|
| Placebo | Drug | 3 capsules at a time, three times a day, duration: 12 weeks |
|
Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value)
| Baseline and Week 4,12 |
| Change from Baseline in the Mean 24h Diastolic Blood Pressure at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Mean daytime Systolic Blood Pressure at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Mean daytime Diastolic Blood Pressure at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Mean nighttime Systolic Blood Pressure at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Mean nighttime Diastolic Blood Pressure at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Mean 24h PP at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the BP load at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Official PP at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Official SBP at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Official DBP at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Official BP Compliance Rate at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Home SBP at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Home DBP at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Proportion of patients with grade 2 or higher hypertension or target organ damage at 12 weeks | Proportion= Number of target patients/Total patients | Week 12 |
| Change from Baseline in the CIMT at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Hypertension Symptom Quantitative Score at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Patient Health Questionnaire-9 Quantitative Score at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Change from Baseline in the Generalized Anxiexy Disorde-7 Quantitative Score at 4,12 weeks | Change=(Week 12 value- Baseline value) and (Week 4 value- Baseline value) | Baseline and Week 4,12 |
| Suzhou Hosptial of Traditional Chinese Medicine | Not yet recruiting | Suzhou | Jiangsu | 215002 | China |
|
| Affiliated Hospital of Shandong University of Traditional Chinese Medicine | Not yet recruiting | Jinan | Shandong | 250013 | China |
|
| China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital | Not yet recruiting | Jining | Shandong | 272000 | China |
|
| China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital | Not yet recruiting | Taiyuan | Shanxi | 030024 | China |
|
| Liu Q, Yu L, Zhang Z, Zhuang Z, Tian W, Wang A, Xu H. The effects of Songling Xuemaikang capsule on vascular remodeling of stage 1 hypertension: a multicenter, randomized placebo-controlled trial protocol. BMC Complement Med Ther. 2025 Aug 6;25(1):300. doi: 10.1186/s12906-025-05038-y. |
| ID | Term |
|---|---|
| D000075222 | Essential Hypertension |
| D066253 | Vascular Remodeling |
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| C000606146 | songling xuemaikang |
Not provided
Not provided
Not provided